Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
Year: 2024
Type: article
Study design: Observational Study
Source: Transplant Infectious Disease
DOI: 10.1111/tid.14377
Institutions: Mayo Clinic, Rush University Medical Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4402939621
